Seema Garde

Author PubWeight™ 6.78^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	Prostate secretory protein PSP-94 decreases tumor growth and hypercalcemia of malignancy in a syngenic in vivo model of prostate cancer.	Cancer Res	2003	1.31
2	A prostate secretory protein94-derived synthetic peptide PCK3145 inhibits VEGF signalling in endothelial cells: implication in tumor angiogenesis.	Int J Cancer	2006	1.00
3	Contribution of the 37-kDa laminin receptor precursor in the anti-metastatic PSP94-derived peptide PCK3145 cell surface binding.	Biochem Biophys Res Commun	2006	0.98
4	A PSP94-derived peptide PCK3145 inhibits MMP-9 secretion and triggers CD44 cell surface shedding: implication in tumor metastasis.	Clin Exp Metastasis	2005	0.95
5	Inhibition of MMP-9 secretion by the anti-metastatic PSP94-derived peptide PCK3145 requires cell surface laminin receptor signaling.	Anticancer Drugs	2006	0.90
6	Prostate secretory protein of 94 amino acids (PSP-94) and its peptide (PCK3145) as potential therapeutic modalities for prostate cancer.	Anticancer Drugs	2005	0.86
7	A synthetic 15-mer peptide (PCK3145) derived from prostate secretory protein can reduce tumor growth, experimental skeletal metastases, and malignancy-associated hypercalcemia.	Cancer Res	2004	0.84